Prothya Biosolutions

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
Apotransferrin in Atransferrinemia	Hemic and Lymphatic Diseases, Nutritional and Metabolic Diseases, anemia, atransferrinemia, hematologic disorder, iron metabolism disease, iron poisoning, metabolic disease	Active, not recruiting	Phase 2	2026-09-16	NCT01797055
Add-on Intravenous Immunoglobulins in Early Myositis	Skin and Connective Tissue Diseases, acquired idiopathic inflammatory myopathy, antisynthetase syndrome, connective tissue disorder, dermatomyositis, immune-mediated necrotizing myopathy, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease, polymyositis, skin disorder	Active, not recruiting	Phase 2 / Phase 3	2026-02-27	NCT05832034
DUPIlumab Dose REDUCtion in Patients With Controlled Atopic Eczema	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder	Recruiting	Phase 4	2025-10-08	NCT06004986

Clinical trials